Red blood cells (RBCs) are a specialised organ that enabled the evolution of multicellular
organisms by supplying a sufficient quantity of oxygen to cells that cannot obtain oxygen …

Since their first description, extracellular vesicles (EVs) have been the topic of avid study in a
variety of physiologic contexts and are now thought to play an important role in cancer. The …

Extracellular vesicles (EVs), such as exosomes and microvesicles, are released by different
cell types and participate in physiological and pathophysiological processes. EVs mediate …

Objective: Exosomes are nanovesicles that are released from normal and tumor cells and
are detectable in cell culture supernatant and human biological fluids. Although previous …

Exosomes (Exos) as drug delivery vehicles have been widely used for cancer
immunotherapy owing to their good biocompatibility, low toxicity, and low immunogenicity …

The accrual of myeloid-derived suppressor cells (MDSCs) represents a major obstacle to
effective immunotherapy in cancer patients, but the mechanisms underlying this process in …

Red blood cells (RBCs) release extracellular vesicles (EVs) including both endosome-
derived exosomes and plasma-membrane-derived microvesicles (MVs). RBC-derived EVs …

The immune response against transplanted allografts is one of the most potent reactions
mounted by the immune system. The acute rejection response has been attributed to donor …

Red blood cell (RBC) transfusion is common in critically ill, postsurgical, and posttrauma
patients in whom both systemic inflammation and immune suppression are associated with …

The discovery of extracellular vesicles (EVs) has revised the interpretation of intercellular
communication. It is now well established that EVs play a significant role in coagulation …